ProfileGDS4718 / 65588_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 64% 70% 72% 69% 92% 95% 73% 68% 71% 74% 72% 77% 91% 94% 79% 69% 86% 86% 78% 78% 73% 72% 74% 71% 92% 74% 90% 73% 91% 80% 88% 66% 75% 91% 98% 86% 75% 69% 75% 69% 85% 80% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0660372
GSM549102patient 115, normal, homogenized [OPG study]6.3745264
GSM549104patient 119, normal, homogenized [OPG study]6.8970670
GSM549108patient 138, normal, homogenized [OPG study]7.0296272
GSM549119patient 077, normal, homogenized [OPG study]6.7582569
GSM549133patient 032, cancer, homogenized [OPG study]9.6793792
GSM549139patient 042, cancer, homogenized [OPG study]10.087895
GSM549099patient 107, normal, homogenized [OPG study]7.0614773
GSM549109patient 139, normal, homogenized [OPG study]6.733468
GSM549110patient 046, normal, homogenized [OPG study]6.8990471
GSM549114patient 063, normal, homogenized [OPG study]7.1979974
GSM549122patient 082, normal, homogenized [OPG study]7.0887872
GSM549134patient 033, cancer, homogenized [OPG study]7.5389277
GSM549136patient 036, cancer, homogenized [OPG study]9.4047491
GSM549140patient 044, cancer, homogenized [OPG study]9.9188894
GSM549111patient 047, normal, homogenized [OPG study]7.740579
GSM549113patient 057, normal, homogenized [OPG study]6.8423969
GSM549132patient 031, cancer, homogenized [OPG study]8.6368386
GSM549137patient 038, cancer, homogenized [OPG study]8.5692386
GSM549142patient 047, cancer, homogenized [OPG study]7.4216678
GSM549100patient 110, normal, homogenized [OPG study]7.6047378
GSM549107patient 135, normal, homogenized [OPG study]7.1895673
GSM549115patient 068, normal, homogenized [OPG study]7.0627672
GSM549116patient 072, normal, homogenized [OPG study]7.2210174
GSM549120patient 078, normal, homogenized [OPG study]6.9879371
GSM549131patient 030, cancer, homogenized [OPG study]9.5099992
GSM549118patient 074, normal, homogenized [OPG study]7.1979374
GSM549129patient 027, cancer, homogenized [OPG study]9.0634790
GSM549123patient 088, normal, homogenized [OPG study]7.1344873
GSM549124patient 006, cancer, homogenized [OPG study]9.1842991
GSM549126patient 015, cancer, homogenized [OPG study]7.86780
GSM549128patient 025, cancer, homogenized [OPG study]8.8749288
GSM549103patient 117, normal, homogenized [OPG study]6.5470966
GSM549117patient 073, normal, homogenized [OPG study]7.2654675
GSM549138patient 041, cancer, homogenized [OPG study]9.3423291
GSM549141patient 045, cancer, homogenized [OPG study]11.245498
GSM549130patient 028, cancer, homogenized [OPG study]8.5114786
GSM549101patient 111, normal, homogenized [OPG study]7.3443375
GSM549105patient 128, normal, homogenized [OPG study]6.8081769
GSM549106patient 134, normal, homogenized [OPG study]7.4195375
GSM549112patient 048, normal, homogenized [OPG study]6.7618269
GSM549125patient 011, cancer, homogenized [OPG study]8.3700985
GSM549127patient 024, cancer, homogenized [OPG study]7.8983680
GSM549135patient 035, cancer, homogenized [OPG study]9.7187793